Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.34 USD | -26.75% | -21.50% | -34.58% |
05-14 | Transcript : Fennec Pharmaceuticals Inc., Q1 2024 Earnings Call, May 14, 2024 | |
05-14 | Fennec Pharmaceuticals Swings to Q1 Profit on Higher Sales, Licensing Revenue | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.58% | 201M | |
+5.33% | 111B | |
+12.11% | 106B | |
-12.56% | 22.24B | |
-3.67% | 21.25B | |
-5.75% | 18.97B | |
-35.21% | 18.52B | |
-10.86% | 16.81B | |
+37.57% | 12.54B | |
-26.24% | 8.09B |
- Stock Market
- Equities
- FENC Stock
- News Fennec Pharmaceuticals Inc.
- Craig-Hallum Assumes Fennec Pharmaceuticals at Buy With $14 Price Target